Evidence map›Paper›PMID 30249265›Full record

ArticleMalaria journal2018

Proteomic profiling of the plasma of Gambian children with cerebral malaria.

Ehab M Moussa, Honglei Huang, Marie L Thézénas, Roman Fischer, Abhinay Ramaprasad, Fatou Sisay-Joof, Muminatou Jallow, Arnab Pain, Dominic Kwiatkowski, Benedikt M Kessler and 1 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Observational
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 4 countries.

Ehab M MoussaWellcome Trust Centre for Human Genetics, Oxford, UK.
Honglei HuangWellcome Trust Centre for Human Genetics, Oxford, UK.
Marie L ThézénasWellcome Trust Centre for Human Genetics, Oxford, UK.
Roman FischerWellcome Trust Centre for Human Genetics, Oxford, UK.
Abhinay RamaprasadWellcome Trust Centre for Human Genetics, Oxford, UK.
Fatou Sisay-JoofMRC Laboratories, Banjul, The Gambia.
Muminatou JallowMRC Laboratories, Banjul, The Gambia.
Arnab PainKing Abdulla University of Science and Technology, Thuwal, Saudi Arabia.
Dominic KwiatkowskiWellcome Trust Centre for Human Genetics, Oxford, UK.
Benedikt M KesslerWellcome Trust Centre for Human Genetics, Oxford, UK.
Climent Casals-PascualWellcome Trust Centre for Human Genetics, Oxford, UK. ccasals@well.ox.ac.uk.ORCID http://orcid.org/0000-0002-0867-8954
Centre for Human Genetics · GBMRC Unit the Gambia · GMKing Abdullah University of Science and Technology · SA

Funding

Medical Research Council G0701885Wellcome Trust 090532/Z/09/ZWellcome Trust 204911/Z/16/Z
6 · The paper itself

Abstract

backgroundCerebral malaria (CM) is a severe neurological complication of Plasmodium falciparum infection. A number of pathological findings have been correlated with pediatric CM including sequestration, platelet accumulation, petechial haemorrhage and retinopathy. However, the molecular mechanisms leading to death in CM are not yet fully understood.

methodsA shotgun plasma proteomic study was conducted using samples form 52 Gambian children with CM admitted to hospital. Based on clinical outcome, children were assigned to two groups: reversible and fatal CM. Label-free liquid chromatography-tandem mass spectrometry was used to identify and compare plasma proteins that were differentially regulated in children who recovered from CM and those who died. Candidate biomarkers were validated using enzyme immunoassays.

resultsThe plasma proteomic signature of children with CM identified 266 proteins differentially regulated in children with fatal CM. Proteins from the coagulation cascade were consistently decreased in fatal CM, whereas the plasma proteomic signature associated with fatal CM underscored the importance of endothelial activation, tissue damage, inflammation, haemolysis and glucose metabolism. The concentration of circulating proteasomes or PSMB9 in plasma was not significantly different in fatal CM when compared with survivors. Plasma PSMB9 concentration was higher in patients who presented with seizures and was significantly correlated with the number of seizures observed in patients with CM during admission.

conclusionsThe results indicate that increased tissue damage and hypercoagulability may play an important role in fatal CM. The diagnostic value of this molecular signature to identify children at high risk of dying to optimize patient referral practices should be validated prospectively.

Indexed as

AdolescentBiomarkersBlood ProteinsChildChild, PreschoolFemaleGambiaHumansInfantMalaria, CerebralMalaria, FalciparumMalePlasmodium falciparumProteomeProteomicsBiomarkersBlood ProteinsProteomeAcute phase reactionBiomarkersCerebral malariaCoagulationPlasmodium falciparumProteasome

Identifiers

PMID30249265
PMCPMC6154937
OpenAlexW2891214005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.